Role of DHEA Supplementation in Adrenal Insufficiency
DHEA supplementation is recommended only for female patients with adrenal insufficiency who experience persistent low libido and/or low energy levels despite optimized glucocorticoid and mineralocorticoid replacement therapy. 1, 2
Indications for DHEA Supplementation
DHEA supplementation should be considered specifically for female patients with adrenal insufficiency who have:
DHEA is not considered essential for life (unlike glucocorticoids and mineralocorticoids) and therefore is not part of routine replacement therapy in adrenal insufficiency 4
Dosing and Administration
- Typical starting dose is 25 mg as a single daily oral dose 1, 2
- Dose range can be 10-50 mg daily, adjusted based on clinical response and laboratory values 1
- Monitoring should include:
Evidence of Benefit
Clinical benefits primarily observed in women with adrenal insufficiency include:
Benefits are more consistently demonstrated in women with adrenal insufficiency than in those with age-related DHEA decline 6
Approach to DHEA Therapy
- First ensure optimal glucocorticoid and mineralocorticoid replacement 1
- Assess for persistent symptoms of low libido, energy, or mood issues 2
- Measure baseline DHEAS, androstenedione, and testosterone levels 2
- Consider a 6-month trial of DHEA (typically 25 mg daily) 1
- Continue therapy only if clinically effective after trial period 1
- Monitor hormone levels periodically to maintain within normal range 2
Important Caveats and Limitations
- Limited objective evidence of clinical benefit from large studies 1, 2
- Long-term effects of DHEA replacement therapy are not well established 1, 4
- Benefits appear more consistent in women with adrenal insufficiency than in those with age-related DHEA decline 6
- DHEA supplementation has shown little benefit in subjects with physiological, age-related decline in DHEA secretion 6
- Safety data for long-term DHEA therapy are lacking 7
Special Considerations
- DHEA replacement may be particularly beneficial for women with adrenal insufficiency who are chronically treated with exogenous glucocorticoids 3
- Some evidence suggests DHEA may have positive effects on bone mineral density in postmenopausal women with adrenal insufficiency 3
- DHEA may help address vulvovaginal atrophy in postmenopausal women with adrenal insufficiency 3